Home / Central Data Catalog / SAFETYEFFECTIVENESSANDIMMUNOGENICITYOFHETEROLOGOUSMRNA-1273BOOST / variable [F2]
central

Safety, Effectiveness and Immunogenicity of heterologous mRNA-1273 Boost

South Africa
Nigel Garrett, Tarylee Reddy, Nonhlanhla Yende-Zuma, Azwidhwi Takalani, Kubashni Woeber, Annie Bodenstein, Phumeza Jonas, Imke Engelbrecht, Waasila Jassat, Harry Moultrie, Debbie Bradshaw, Ishen Seocharan, Jackline Odhiambo, Kentse Khuto, Simone I. Richardson, Millicent A. Omondi, Rofhiwa Nesamari,
Created on April 29, 2024 Last modified April 29, 2024 Page views 24516 Download 2 Documentation in PDF Metadata DDI/XML JSON
CSV JSON

aspirin (aspirin)

Data file: SHERPA_Safetydata

Overview

Valid: 6245
Invalid: 0
Type: Discrete
Width: 3
Range: -
Format: character

Questions and instructions

Categories
Value Category Cases
No 6007
96.2%
Yes 238
3.8%
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.